Altimmune (NASDAQ:ALT – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares Altimmune and Purple Biotech’s […]
Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple